NM_001347952.2:c.-139-71110G>A
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001347952.2(RPH3A):c.-139-71110G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.151 in 152,010 control chromosomes in the GnomAD database, including 1,813 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001347952.2 intron
Scores
Clinical Significance
Conservation
Publications
- neurodevelopmental disorderInheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, PanelApp Australia
- complex neurodevelopmental disorderInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- congenital myasthenic syndromeInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001347952.2. You can select a different transcript below to see updated ACMG assignments.
Frequencies
GnomAD3 genomes AF: 0.150 AC: 22842AN: 151892Hom.: 1791 Cov.: 32 show subpopulations
GnomAD4 genome AF: 0.151 AC: 22921AN: 152010Hom.: 1813 Cov.: 32 AF XY: 0.149 AC XY: 11100AN XY: 74304 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at